Risk factors for eight common cancers revealed from a phenome-wide Mendelian randomisation analysis of 378,142 cases and 485,715 controls.

Cancer Mendelian randomisation aetiology genome wide association study risk

Journal

medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986

Informations de publication

Date de publication:
06 Apr 2023
Historique:
pubmed: 18 4 2023
medline: 18 4 2023
entrez: 17 4 2023
Statut: epublish

Résumé

For many cancers there are few well-established risk factors. Summary data from genome-wide association studies (GWAS) can be used in a Mendelian randomisation (MR) phenome-wide association study (PheWAS) to identify causal relationships. We performed a MR-PheWAS of breast, prostate, colorectal, lung, endometrial, oesophageal, renal, and ovarian cancers, comprising 378,142 cases and 485,715 controls. To derive a more comprehensive insight into disease aetiology we systematically mined the literature space for supporting evidence. We evaluated causal relationships for over 3,000 potential risk factors. In addition to identifying well-established risk factors (smoking, alcohol, obesity, lack of physical activity), we provide evidence for specific factors, including dietary intake, sex steroid hormones, plasma lipids and telomere length as determinants of cancer risk. We also implicate molecular factors including plasma levels of IL-18, LAG-3, IGF-1, CT-1, and PRDX1 as risk factors. Our analyses highlight the importance of risk factors that are common to many cancer types but also reveal aetiological differences. A number of the molecular factors we identify have the potential to be biomarkers. Our findings should aid public health prevention strategies to reduce cancer burden. We provide a R/Shiny app (https://mrcancer.shinyapps.io/mrcan/) to visualise findings.

Identifiants

pubmed: 37066289
doi: 10.1101/2023.02.15.23285952
pmc: PMC10104236
pii:
doi:

Types de publication

Preprint

Langues

eng

Déclaration de conflit d'intérêts

CONFLICT-OF-INTEREST DISCLOSURE The authors declare no competing financial interests.

Auteurs

Molly Went (M)

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.

Amit Sud (A)

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Haemato-oncology Unit, The Royal Marsden Hospital NHS Foundation Trust, Sutton, UK.

Charlie Mills (C)

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.

Abi Hyde (A)

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.

Richard Culliford (R)

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.

Philip Law (P)

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.

Jayaram Vijayakrishnan (J)

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.

Ines Gockel (I)

Department of Visceral, Transplant, Thoracic and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany.

Carlo Maj (C)

Center for Human Genetics, University Hospital of Marburg, Marburg, Germany.

Johannes Schumacher (J)

Center for Human Genetics, University Hospital of Marburg, Marburg, Germany.

Claire Palles (C)

Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.

Martin Kaiser (M)

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Haemato-oncology Unit, The Royal Marsden Hospital NHS Foundation Trust, Sutton, UK.

Richard Houlston (R)

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.

Classifications MeSH